FOXO3 and glioblastoma: We selected SOX2 as a marker of stem-like cells because it has been used as a GSC marker in a number of studies and has been proposed to be a therapeutic target in GBM.23,71,72 Many cases exhibited strongly positive FOXO3 staining, where FOXO3 was clearly localized to the nucleus of tumor cells (Figure 2A–C).